A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation.

The aim of this study was to investigate two different processes to produce a stable influenza subunit vaccine powder for pulmonary immunization i.e. spray drying (SD) and spray freeze drying (SFD). The formulations were analyzed by proteolytic assay, single radial immunodiffusion assay (SRID), cascade impactor analysis, and immunization studies in Balb/c mice. Proteolytic assay and SRID analysis showed that antigen integrity after SFD was best conserved when the formulation was buffered by Hepes buffer saline (HBS). Surprisingly, antigen integrity after SD was better conserved when the formulation was buffered by phosphate buffer saline (PBS) rather than by HBS. The dispersion from the dry powder inhaler, the Twincer, resulted in a fine particle fraction (aerodynamic particle size <5microm) of 37% and 23% for spray dried and spray freeze dried powders, respectively. Immunogenicity of both vaccine formulations (SFD/HBS and SD/PBS) was similar to conventional liquid formulation after i.m. immunization. In addition, compared to i.m. immunizations, the pulmonary immunization with the dry powders resulted in significantly higher IgG titers. Furthermore, both the formulations remained biochemically and physically stable for at least 3years of storage at 20 degrees C. Our results demonstrate that both optimized formulations are stable and have good inhalation characteristics.

[1]  W. Hinrichs,et al.  Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  S. Bhowmick,et al.  Moisture sorption characteristics and thermophysical properties of trehalose-PBS mixtures. , 2006, Cryobiology.

[3]  Gideon Kersten,et al.  Needle-free vaccine delivery , 2007, Expert opinion on drug delivery.

[4]  H. Frijlink,et al.  Inulin glasses for the stabilization of therapeutic proteins. , 2001, International journal of pharmaceutics.

[5]  Y. Maa,et al.  The effect of operating and formulation variables on the morphology of spray-dried protein particles. , 1997, Pharmaceutical development and technology.

[6]  T. Francis,et al.  Immunization Against Influenza. , 1946, American journal of public health and the nation's health.

[7]  Dexiang Chen,et al.  Heat-stable measles vaccine produced by spray drying. , 2010, Vaccine.

[8]  H. Frijlink,et al.  Investigations into the stabilisation of drugs by sugar glasses: II. Delivery of an inulin-stabilised alkaline phosphatase in the intestinal lumen via the oral route. , 2003, International journal of pharmaceutics.

[9]  L. van den Berg,et al.  Effect of freezing on the pH and composition of sodium and potassium phosphate solutions; the reciprocal system KH2PO4-Na2-HPO4-H2O. , 1959, Archives of biochemistry and biophysics.

[10]  Albert H. L. Chow,et al.  Particle Engineering for Pulmonary Drug Delivery , 2007, Pharmaceutical Research.

[11]  M. Pikal,et al.  Effect of Initial Buffer Composition on pH Changes During Far-From-Equilibrium Freezing of Sodium Phosphate Buffer Solutions , 2004, Pharmaceutical Research.

[12]  N Lotan,et al.  Large porous particles for pulmonary drug delivery. , 1997, Science.

[13]  J. Carpenter,et al.  An infrared spectroscopic study of the interactions of carbohydrates with dried proteins. , 1989, Biochemistry.

[14]  R. W. Howell,et al.  A comparative trial of influenza immunization by inhalation and hypojet methods. , 1973, Practitioner.

[15]  W. Hinrichs,et al.  Development of Stable Influenza Vaccine Powder Formulations: Challenges and Possibilities , 2008, Pharmaceutical Research.

[16]  P S Kim,et al.  Influenza hemagglutinin is spring-loaded by a metastable native conformation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Vincent J. Sullivan,et al.  A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats. , 2004, Vaccine.

[18]  W. Hinrichs,et al.  The development of stable influenza vaccine powder formulations for new needle-free dosage forms , 2017 .

[19]  H. Frijlink,et al.  5 Design and in vitro performance testing of multiple air classifier technology in a new disposable inhaler concept ( Twincer ® ) for high powder doses , 2009 .

[20]  W. Hinrichs,et al.  Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice. , 2007, Vaccine.

[21]  W. Jiskoot,et al.  Physicochemical studies on the stability of influenza haemagglutinin in vaccine bulk material. , 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  M. Ameri,et al.  Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. , 2004, Journal of pharmaceutical sciences.

[23]  T. Anchordoquy,et al.  Stabilization of lipid/DNA complexes during the freezing step of the lyophilization process: the particle isolation hypothesis. , 2000, Biochimica et biophysica acta.

[24]  F. Booy,et al.  Effects of low pH on influenza virus. Activation and inactivation of the membrane fusion capacity of the hemagglutinin. , 1987, The Journal of biological chemistry.

[25]  Louise Slade,et al.  Water and the glass transition — Dependence of the glass transition on composition and chemical structure: Special implications for flour functionality in cookie baking , 1994 .

[26]  H. Frijlink,et al.  Design and application of a new modular adapter for laser diffraction characterization of inhalation aerosols. , 2002, International journal of pharmaceutics.

[27]  H W Frijlink,et al.  Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. , 2006, International journal of pharmaceutics.

[28]  J. Remon,et al.  Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine. , 2009, Vaccine.

[29]  J. S. Neill,et al.  An evaluation of influenza immunization: influence of route of administration and vaccine strain. , 1969, Bulletin of the World Health Organization.

[30]  Mayank M. Patel,et al.  The stability of lyophilized lipid/DNA complexes during prolonged storage. , 2004, Journal of pharmaceutical sciences.

[31]  Johnson,et al.  Preparation of peptide and protein powders for inhalation. , 1997, Advanced drug delivery reviews.

[32]  Steven J. Shire,et al.  Protein Inhalation Powders: Spray Drying vs Spray Freeze Drying , 1999, Pharmaceutical Research.

[33]  P. Small,et al.  Immunization Against Influenza: Prevention of Illness in Man by Aerosolized Inactivated Vaccine , 1969 .

[34]  H. Frijlink,et al.  Inulin is a promising cryo- and lyoprotectant for PEGylated lipoplexes. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[35]  R. Rappuoli,et al.  Oral Spray Immunization May Be an Alternative to Intranasal Vaccine Delivery to Induce Systemic Antibodies but not Nasal Mucosal or Cellular Immunity , 2006, Scandinavian journal of immunology.

[36]  D. Hincha,et al.  Fructan and its relationship to abiotic stress tolerance in plants , 2009, Cellular and Molecular Life Sciences.

[37]  H. Staats,et al.  Novel dry powder preparations of whole inactivated influenza virus for nasal vaccination , 2007, AAPS PharmSciTech.

[38]  B. Bloom,et al.  Drying a tuberculosis vaccine without freezing , 2007, Proceedings of the National Academy of Sciences.

[39]  J. C. Kapteyn,et al.  Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. , 2006, Vaccine.

[40]  H. Frijlink,et al.  Dry powder inhalers for pulmonary drug delivery , 2004, Expert opinion on drug delivery.

[41]  R. Blumenthal,et al.  Acid-induced changes in thermal stability and fusion activity of influenza hemagglutinin. , 2002, Biochemistry.

[42]  R. W. Howell,et al.  The efficacy of the A2/Aichi/68 strain in inhaled influenza immunisation against the A/England/42/72 variant. , 1973, The Journal of the Society of Occupational Medicine.

[43]  A. Bot,et al.  Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus. , 2003, Vaccine.